|
|
|
| MRI and clinicopathological analysis of ovarian immature teratoma |
1. Department of Radiology, Affiliated Suzhou Hospital, Nanjing Medical University, Suzhou Jiangsu 215002, China;
2. Department of Radiology, the Second Affiliated Hospital of Soochow University, Suzhou Jiangsu 215004, China |
|
|
|
|
Abstract Objective: To investigate the MR findings of ovarian immature teratoma and to correlate MR findings with pathological grading and clinical staging. Materials and Methods: The MR findings and pathology results of nine cases with pathologically proven immature teratoma were analyzed retrospectively. Comparisons between the MR findings and pathological grades and FIGO stages were evaluated by Spearman rank-order correlation. Results: On MR images all lesions appeared to be fat-containing tumors with solid components consisting of numerous cysts. According to the relative volume of solid components, the MR findings of the ovarian immature teratoma can be divided into three types: predominant fluid components(2 cases), mixed with fluid and solid components(5 cases) and predominant solid components(2 cases). The solid components showed heterogeneous signal intensity on MR images, containing numerous long T1 and long T2 signal of cystic area of various sizes. Scattered short T1, long T2 signal of fat foci and long T1, short T2 signal of calcifications were identified in all lesions. The solid components revealed significant contrast enhancement with reticular form. The fluid content exhibited signal intensities similar to simple fluid. The correlation coefficient of Spearman of the MR types and pathological grades was 0.3 and the correlation coefficient of the MR types and FIGO stages was 0.216, the differences were all not statistically significant(P＞0.05). Conclusion: The MR findings of ovarian immature teratoma have some characteristics. There are no significant correlation between the MR types and pathologic grades, and between the MR types and FIGO stages.
|
|
Received: 11 August 2015
|
|
|
|
|
|
[1]Kandukuri SR, Rao J. FIGO 2013 staging system for ovarian cancer: what is new in comparison to the 1988 staging system?[J]. Curr Opin Obstet Gynecol, 2015, 27(1): 48-52.
[2]Deodhar KK, Suryawanshi P, Shah M, et al. Immature teratoma of the ovary: a clinicopathological study of 28 cases[J]. Indian J Pathol Microbiol, 2011, 54(4): 730-735.
[3]Saba L, Guerriero S, Sulcis R, et al. Mature and immature ovarian teratomas: CT, US and MR imaging characteristics[J]. Eur J Radiol, 2009, 72(3): 454-463.
[4]Yamaoka T, Togashi K, Koyama T, et al. Immature teratoma of the ovary: correlation of MR imaging and pathologic findings[J]. Eur Radiol, 2003, 13(2): 313-319.
[5]方如旗，曹代荣，翁淑萍，等. 卵巢未成熟畸胎瘤的CT、MRI表现（附8例报告）[J]. 临床放射学杂志，2012，31（4）：541-544.
[6]沈爱军，戴工华，毛新清，等. 卵巢畸胎瘤的MRI诊断及临床病理基础[J]. 中国临床医学影像杂志，2011，22（5）：367-369.
[7]陈晨，李俊东，黄鹤，等. 肿瘤标志物检测对卵巢成熟、未成熟畸胎瘤的诊断价值[J]. 癌症，2008，27（1）：92-95.
[8]Norris HJ, Howard JZ, Benson WL. Immature(malignant) teratoma of the ovary: a clinical and pathologic study of 58 cases[J]. Cancer, 1976, 37(5): 2359-2372.
[9]郭翠霞，汪龙霞，王昀. 卵巢未成熟畸胎瘤超声表现与病理分级相关性研究[J]. 中华临床医师杂志：电子版，2013，7（21）：9564-9567.
[10]Dede M, Gungor S, Yenen MC, et al. CA19-9 may have clinical significance in mature cystic teratomas of the ovary[J]. Int J Gynecol Cancer, 2006, 16(1): 189-193.
[11]Park SB, Kim JK, Kim KR, et al. Imaging findings of complications and unusual manifestations of ovarian teratomas[J]. Radiographics, 2008, 28(4): 969-983. |
|
|
|
